PeptideDB

Purine 120-73-0

Purine 120-73-0

CAS No.: 120-73-0

Purine is an endogenously produced metabolite.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Purine is an endogenously produced metabolite.

Physicochemical Properties


Molecular Formula C5H4N4
Molecular Weight 120.11
Exact Mass 120.043
CAS # 120-73-0
PubChem CID 1044
Appearance Off-white to gray solid powder
Density 1.5±0.1 g/cm3
Boiling Point 424ºC at 760mmHg
Melting Point 214-217 °C(lit.)
Flash Point 225.4ºC
Vapour Pressure 0.0976mmHg at 25°C
Index of Refraction 1.738
LogP -0.37
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 0
Heavy Atom Count 9
Complexity 105
Defined Atom Stereocenter Count 0
InChi Key KDCGOANMDULRCW-UHFFFAOYSA-N
InChi Code

InChI=1S/C5H4N4/c1-4-5(8-2-6-1)9-3-7-4/h1-3H,(H,6,7,8,9)
Chemical Name

7H-purine
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets Human Endogenous Metabolite
Additional Infomation 7H-purine is the 7H-tautomer of purine. It is a tautomer of a 1H-purine, a 3H-purine and a 9H-purine.
Purine is a metabolite found in or produced by Escherichia coli (strain K12, MG1655).
Purine has been reported in Homo sapiens, Panax ginseng, and Bos taurus with data available.
Purine is a metabolite found in or produced by Saccharomyces cerevisiae.

Solubility Data


Solubility (In Vitro) DMSO :~50 mg/mL (~416.29 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (20.81 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (20.81 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (20.81 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 8.3257 mL 41.6285 mL 83.2570 mL
5 mM 1.6651 mL 8.3257 mL 16.6514 mL
10 mM 0.8326 mL 4.1629 mL 8.3257 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.